BOULDER, Colo., Oct. 23, 2018 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) will report financial results
for the first quarter of fiscal 2019 and hold a conference call to
discuss those results on Tuesday, October
30, 2018. Ron Squarer, Chief Executive Officer, will lead
the call.
|
Date:
|
Tuesday, October 30,
2018
|
|
Time:
|
9:00 a.m.
Eastern Time
|
|
Toll-Free:
|
(844)
464-3927
|
|
Toll:
|
(765)
507-2598
|
|
Pass
Code:
|
5559328
|
Webcast, including Replay and Conference Call Slides:
https://edge.media-server.com/m6/p/kdv5h8qp
About Array BioPharma
Array BioPharma Inc. is a
fully-integrated, biopharmaceutical company focused on the
discovery, development and commercialization of transformative and
well-tolerated targeted small molecule drugs to treat patients
afflicted with cancer and other high-burden diseases. Array markets
in the United States
BRAFTOVI® (encorafenib) capsules in combination with
MEKTOVI® (binimetinib) tablets for the treatment of
patients with unresectable or metastatic melanoma with a
BRAFV600E or BRAFV600K
mutation. Array's lead clinical programs, encorafenib and
binimetinib, are being investigated in over 30 clinical trials
across a number of solid tumor indications, including a Phase 3
trial in BRAF-mutant colorectal cancer. Array's pipeline
includes several additional programs being advanced by Array or
current license-holders, including the following programs currently
in registration trials: selumetinib (partnered with AstraZeneca),
larotrectinib and LOXO-292 (partnered with Loxo Oncology),
ipatasertib (partnered with Genentech), tucatinib (partnered with
Seattle Genetics) and ARRY-797. Ganovo® (danoprevir,
partnered with Roche) was recently approved in China for the treatment of viral hepatitis C.
For more information on Array, please visit www.arraybiopharma.com
or follow @arraybiopharma on Twitter and LinkedIn.
CONTACT:
Array BioPharma
Andrea N. Flynn, Ph.D.
Senior Director, Investor Relations & Corporate
Communications
(303) 381-6600
ir@arraybiopharma.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-first-quarter-of-fiscal-2019-on-october-30-2018-300735608.html
SOURCE Array BioPharma